Chardan Capital Maintains Krystal Biotech (KRYS) Buy Recommendation
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Fintel reports that on May 22, 2023, Chardan Capital maintained coverage of Krystal Biotech (NASDAQ:KRYS) with a Buy recommendation.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1190995919-bce27cedc8fa4274b70ffcd0062e6098.jpg "A Brief History of Taxes in the U.S.")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1197604583-751ff7a9d28a483e88f3cd61b6635324.jpg "How to Fund a Dream Vacation With a Home Equity Loan")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1152013583-a5bad8090c064339bf7880b7c9012379.jpg "Which Terms Should Be Included in a Partnership Agreement?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1153697801-575a3cdd2f2448a68677dde062945ac2.jpg "<div>Standard of Living vs. Quality of Life: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/Zero-CostStrategyWhatitisHowitWorksExamples-fae03bac9671486ca26a4f6fd76290fe.jpg "Popular Careers in the Financial Sector")
